US drug regulator classifies Aurobindo Pharma arm's Andhra facility as 'voluntary action indicated'

Wait 5 sec.

Aurobindo Pharma Limited has announced that its subsidiary, Apitoria Pharma Pvt Ltd, received a VAI classification for its facility. The classification indicates that some objectionable conditions were found, but no regulatory actions will occur. The inspection took place from August 24 to August 28, 2026, by the USFDA.